<?xml version="1.0" encoding="UTF-8"?>
<p id="para0007">Shifting drugs with proven activity against other diseases to SARS-CoV-2 empiric treatment is leading to a drug global shortage, that can significantly impact on the quality of life of those patients, such as those affected by SLE and AR, who could face hydroxychloroquine stock exhaustion.
 <xref rid="bib0008" ref-type="bibr">
  <sup>8</sup>
 </xref> Conversely, preliminary data about a potential role of ACE inhibitors in favouring the onset of severe forms of SARS-CoV-2 infection induced a massive change in antihypertensive drugs prescription that caused the onset of severe cardiovascular events.
 <xref rid="bib0009" ref-type="bibr">
  <sup>9</sup>
 </xref>
</p>
